Former Johnson & Johnson Senior Executive to Lead New Early Stage Diabetes Device Company

Share Article

Smart Meter Corporation, a New York company developing innovative diabetes medical devices including the iGlucose® Blood Glucose Monitoring System, recently announced that Wycliffe (Cliff) X. McIntosh has joined the company as their Chief Executive Officer.

“We are delighted to obtain someone who has broad leadership experience, demonstrated global brand development success, and an outstanding work knowledge of the diabetes space," said Ron Ostroff, Smart Meter's Chairman

Smart Meter Corporation, a New York company developing innovative diabetes medical devices including the iGlucose® Blood Glucose Monitoring System, recently announced that Wycliffe (Cliff) X. McIntosh has joined the company as their Chief Executive Officer.

“We are delighted to obtain someone who has broad leadership experience, demonstrated global brand development success, and an outstanding work knowledge of the diabetes space. We look forward to Cliff’s contribution in building our unique brand value and leading us to commercial success,” said Ron Ostroff, Smart Meter’s Chairman.

Cliff McIntosh has over 30 years of medical device and diagnostic experience with much of his knowledge coming from his senior commercial roles at Johnson & Johnson and several early stage medical device companies. During his tenure with the multi-national medical device, pharmaceutical, and consumer goods manufacturer, he was responsible for establishing blood glucose monitoring market leadership across international regions and launched the successful LifeScan* One Touch®* brand in Asia, Europe, the Middle East, and Africa. He was also instrumental in creating the global Johnson & Johnson Diabetes Institute and plans to continue his success with the iGlucose® Blood Glucose Monitoring System.

“Today, people with diabetes, and their caregivers, still have many unmet needs. I am elated to join the team at this stage of the company’s evolution and play a key role in launching innovative diabetes technologies that will help define a new level of user engagement in the healthcare continuum,” said Cliff McIntosh. “Providing simple tools to help people with diabetes master their condition, seamlessly connect with their support team, and together eliminate potential complications will ultimately improve the quality of life for people around the world.”

Diabetes is a demanding disease. Easy access to actionable information and assistance from a wide array of caregivers has been shown to be effective in making informed decisions. The iGlucose® Blood Glucose Monitor allows users to easily and instantly send their blood glucose results from their meter via text message, email, or fax to multiple family members, caregivers, or physicians without the use of a smartphone or cables. Users and their selected providers have access to personalized data and useful reports online 24 hours a day, 7 days a week, 365 days a year, and the system may be used worldwide.

For more information, visit iGlucose.com or follow the iGlucose social media channels on Facebook, Twitter, and Pinterest.

The iGlucose® Blood Glucose Monitoring System is investigational. It is not yet cleared for sale in the USA by the Food and Drug Administration.

About Smart Meter Corporation:
Smart Meter Corporation is a New York based company that develops innovative diabetes medical devices to allow connection, solutions, and support to people with diabetes, their doctors, and their loved ones.

*LifeScan and One Touch are trademarks of Johnson & Johnson

Contact:
Giana Pacinelli
368 New Hempstead Rd., Suite 309
New City, NY 10956
marketing(at)iglucose(dot)com
954-648-6552

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Giana Pacinelli
iGlucose
+1 9543322200 Ext: 1005
Email >

Michelle Esposito
@iGlucoseMeter
since: 04/2014
Follow >
IGlucoseMeter
since: 05/2014
Like >
Follow us on
Visit website